ANIK - Anika Therapeutics to reduce workforce by 9%
2024-03-14 03:10:40 ET
More on Anika Therapeutics
- Anika Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M
- Seeking Alpha’s Quant Rating on Anika Therapeutics
- Historical earnings data for Anika Therapeutics